From: Role of endothelial miR-24 in COVID-19 cerebrovascular events
COVID-19 negative | COVID-19 positive | |||||
---|---|---|---|---|---|---|
NO CBV | CBV | P | NO CBV | CBV | P | |
(57) | (37) | (263) | (58) | |||
Age (years) | 59.4 ± 14.78 | 65.37 ± 12.75* | 0.04 | 61.5 ± 14.2 | 63.6 ± 14.6 | 0.292 |
Sex (male, %) | 50.9 | 59.5 | 0.42 | 54.7 | 55.1 | 0.954 |
BMI (kg/m2) | 25.62 ± 3.83 | 25.44 ± 2.9 | 0.8 | 24.93 ± 3.59 | 25.01 ± 2.9 | 0.865 |
SBP (mmHg) | 133.88 ± 16.1 | 143.08 ± 19.3* | 0.014 | 137.76 ± 19.5 | 142.2 ± 19.3 | 0.114 |
DBP (mmHg) | 79.93 ± 9.5 | 84.38 ± 8.8* | 0.025 | 84.46 ± 9.47 | 86.3 ± 14.9 | 0.239 |
Hypertension (%) | 26.3 | 51.3* | 0.013 | 39.9 | 44.8 | 0.493 |
Glycemia (mg/dl) | 104.9 ± 22.2 | 112.2 ± 27.8 | 0.163 | 109.39 ± 28.2 | 112.48 ± 42.7 | 0.497 |
Diabetes (%) | 7.0 | 21.6* | 0.039 | 12.5 | 17.2 | 0.344 |
Dyslipidemia (%) | 24.5 | 43.2 | 0.059 | 30.8 | 34.4 | 0.586 |
Smoking (current/past, %) | 14/22.8 | 21.6/37.8* | 0.032 | 18.2/26.6 | 12.1/34.4# | 0.081 |
D-dimer (µg/ml) | 2.35 ± 1.73 | 3.52 ± 0.95* | 0.001 | 2.80 ± 1.68 | 3.18 ± 1.83 | 0.120 |
IL-6 (pg/ml) | 1.7 ± 1.1 | 4.0 ± 2.8* | 0.002 | 7.5 ± 4.0# | 8.4 ± 5.5# | 0.121 |
TNFα (pg/ml) | 4.5 ± 2.3 | 6.0 ± 4.7* | 0.035 | 6.5 ± 4.2 | 5.8 ± 4.7 | 0.271 |
hs-CRP (µg/ml) | 2.15 ± 1.1 | 2.6 ± 1.16 | 0.07 | 3.6 ± 3.2# | 4.2 ± 2.9# | 0.144 |
EC-EV miR-24 (copies/10 nl) | 30.5 ± 14.6 | 29.85 ± 15.5 | 0.827 | 26.64 ± 20.9# | 15.41 ± 14.7*,# | 0.001 |